These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31929426)
21. Adherence to medical recommendations and transition to adult services in pediatric transplant recipients. Shemesh E; Annunziato RA; Arnon R; Miloh T; Kerkar N Curr Opin Organ Transplant; 2010 Jun; 15(3):288-92. PubMed ID: 20445451 [TBL] [Abstract][Full Text] [Related]
22. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients. Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247 [TBL] [Abstract][Full Text] [Related]
23. Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies. Doyle IC; Maldonado AQ; Heldenbrand S; Tichy EM; Trofe-Clark J Am J Health Syst Pharm; 2016 Jun; 73(12):909-20. PubMed ID: 27189855 [No Abstract] [Full Text] [Related]
24. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? Nerini E; Bruno F; Citterio F; Schena FP J Nephrol; 2016 Oct; 29(5):627-36. PubMed ID: 26885659 [TBL] [Abstract][Full Text] [Related]
25. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients. Everly MJ Clin Transpl; 2011; ():319-25. PubMed ID: 22755425 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671 [TBL] [Abstract][Full Text] [Related]
27. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. Davis S; Gralla J; Klem P; Stites E; Wiseman A; Cooper JE Transplantation; 2020 Apr; 104(4):881-887. PubMed ID: 32224815 [TBL] [Abstract][Full Text] [Related]
28. Update on Chronic Rejection After Intestinal Transplant: An Overview From Experimental Settings to Clinical Outcomes. Lauro A; Marino IR Exp Clin Transplant; 2019 Jan; 17(Suppl 1):18-30. PubMed ID: 30777519 [TBL] [Abstract][Full Text] [Related]
29. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
30. Impact of a Mobile Health Intervention on Long-term Nonadherence After Lung Transplantation: Follow-up After a Randomized Controlled Trial. Geramita EM; DeVito Dabbs AJ; DiMartini AF; Pilewski JM; Switzer GE; Posluszny DM; Myaskovsky L; Dew MA Transplantation; 2020 Mar; 104(3):640-651. PubMed ID: 31335759 [TBL] [Abstract][Full Text] [Related]
32. The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation. Karpen SR; Klein A; Alloway RR; Albrecht R; Belen O; Campbell M; Kluetz P; Minasian LM; Mitchell SA; O'Doherty I; Papadopoulos E; Sapir-Pichhadze R; Spear N; van Gelder T; Velidedeoglu E; Page CA; Everly MJ Transplantation; 2021 May; 105(5):941-944. PubMed ID: 33901129 [No Abstract] [Full Text] [Related]
33. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort. Shemesh E; Duncan S; Anand R; Shneider BL; Alonso EM; Mazariegos GV; Venick RS; Annunziato RA; Bucuvalas JC Liver Transpl; 2018 Jan; 24(1):80-88. PubMed ID: 28779546 [TBL] [Abstract][Full Text] [Related]
34. Using HLA antibody detection, monitoring, and treatment to improve long-term allograft survival. Everly MJ Clin Transpl; 2010; ():317-22. PubMed ID: 21696049 [TBL] [Abstract][Full Text] [Related]
35. eHealth Interventions for Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Tang J; James L; Howell M; Tong A; Wong G Transplantation; 2020 Aug; 104(8):e224-e235. PubMed ID: 32732828 [TBL] [Abstract][Full Text] [Related]
36. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort. Charnaya O; Tuchman S; Moudgil A Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29356221 [TBL] [Abstract][Full Text] [Related]
37. Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside. Focosi D Int Rev Immunol; 2016 Jul; 35(4):351-368. PubMed ID: 27120091 [TBL] [Abstract][Full Text] [Related]
38. Impact of donor-specific HLA antibodies in transplantation, a review of the literature published in the last three years. Kaneku H Clin Transpl; 2010; ():283-306. PubMed ID: 21696047 [TBL] [Abstract][Full Text] [Related]
39. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Taber DJ; Pilch NA; McGillicuddy JW; Mardis C; Treiber F; Fleming JN Am J Health Syst Pharm; 2019 Jul; 76(15):1143-1149. PubMed ID: 31361870 [TBL] [Abstract][Full Text] [Related]
40. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Couzi L; Moulin B; Morin MP; Albano L; Godin M; Barrou B; Alamartine E; Morelon E; Girardot-Seguin S; Mendes L; Misdrahi D; Cassuto E; Merville P Transplantation; 2013 Jan; 95(2):326-32. PubMed ID: 23149477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]